These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35277742)

  • 1. Deep learning-based attenuation correction for whole-body PET - a multi-tracer study with
    Toyonaga T; Shao D; Shi L; Zhang J; Revilla EM; Menard D; Ankrah J; Hirata K; Chen MK; Onofrey JA; Lu Y
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3086-3097. PubMed ID: 35277742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning-based attenuation map generation with simultaneously reconstructed PET activity and attenuation and low-dose application.
    Shi L; Zhang J; Toyonaga T; Shao D; Onofrey JA; Lu Y
    Phys Med Biol; 2023 Jan; 68(3):. PubMed ID: 36584395
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of PET Attenuation Map for Whole-Body Time-of-Flight
    Hwang D; Kang SK; Kim KY; Seo S; Paeng JC; Lee DS; Lee JS
    J Nucl Med; 2019 Aug; 60(8):1183-1189. PubMed ID: 30683763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of a deep learning-based framework to generate whole-body attenuation maps using LSO background radiation in long axial FOV PET scanners.
    Sari H; Teimoorisichani M; Mingels C; Alberts I; Panin V; Bharkhada D; Xue S; Prenosil G; Shi K; Conti M; Rominger A
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4490-4502. PubMed ID: 35852557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of maximum likelihood and conventional PET scatter scaling methods for
    Bal H; Kiser JW; Conti M; Bowen SL
    Med Phys; 2021 Aug; 48(8):4218-4228. PubMed ID: 34013586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the Accuracy of Simultaneously Reconstructed Activity and Attenuation Maps Using Deep Learning.
    Hwang D; Kim KY; Kang SK; Seo S; Paeng JC; Lee DS; Lee JS
    J Nucl Med; 2018 Oct; 59(10):1624-1629. PubMed ID: 29449446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of MRI-guided attenuation correction techniques in time-of-flight brain PET/MRI.
    Mehranian A; Arabi H; Zaidi H
    Neuroimage; 2016 Apr; 130():123-133. PubMed ID: 26853602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative clinical evaluation of simultaneous reconstruction of attenuation and activity in time-of-flight PET.
    Zhang H; Wang J; Li N; Zhang Y; Cui J; Huo L; Zhang H
    BMC Med Imaging; 2023 Feb; 23(1):35. PubMed ID: 36849906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of deep learning-based emission-only attenuation correction methods for positron emission tomography.
    Hwang D; Kang SK; Kim KY; Choi H; Lee JS
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1833-1842. PubMed ID: 34882262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep-JASC: joint attenuation and scatter correction in whole-body
    Shiri I; Arabi H; Geramifar P; Hajianfar G; Ghafarian P; Rahmim A; Ay MR; Zaidi H
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2533-2548. PubMed ID: 32415552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for deep learning-based attenuation and scatter correction of brain
    Jahangir R; Kamali-Asl A; Arabi H; Zaidi H
    Med Phys; 2024 Feb; 51(2):870-880. PubMed ID: 38197492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning-Based Noninvasive Quantification of Single-Imaging Session Dual-Tracer
    Ding W; Yu J; Zheng C; Fu P; Huang Q; Feng DD; Yang Z; Wahl RL; Zhou Y
    IEEE Trans Med Imaging; 2022 Feb; 41(2):347-359. PubMed ID: 34520350
    [No Abstract]   [Full Text] [Related]  

  • 15. Data-driven respiratory phase-matched PET attenuation correction without CT.
    Hwang D; Kang SK; Kim KY; Choi H; Seo S; Lee JS
    Phys Med Biol; 2021 May; 66(11):. PubMed ID: 33910170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
    Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
    Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Assessment of Emission- and Segmentation-Based MR-Guided Attenuation Correction in Whole-Body Time-of-Flight PET/MR Imaging.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Jun; 56(6):877-83. PubMed ID: 25858043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracers.
    Grafe H; Lindemann ME; Ruhlmann V; Oehmigen M; Hirmas N; Umutlu L; Herrmann K; Quick HH
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2269-2279. PubMed ID: 32125487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
    Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
    Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.